These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12897976)

  • 61. A chimeric multi-epitope DNA vaccine elicited specific antibody response against severe acute respiratory syndrome-associated coronavirus which attenuated the virulence of SARS-CoV in vitro.
    Wang X; Xu W; Tong D; Ni J; Gao H; Wang Y; Chu Y; Li P; Yang X; Xiong S
    Immunol Lett; 2008 Aug; 119(1-2):71-7. PubMed ID: 18533276
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.
    Liu YV; Massare MJ; Barnard DL; Kort T; Nathan M; Wang L; Smith G
    Vaccine; 2011 Sep; 29(38):6606-13. PubMed ID: 21762752
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mapping a neutralizing epitope on the SARS coronavirus spike protein: computational prediction based on affinity-selected peptides.
    Tarnovitski N; Matthews LJ; Sui J; Gershoni JM; Marasco WA
    J Mol Biol; 2006 May; 359(1):190-201. PubMed ID: 16630634
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies.
    Zhang H; Wang G; Li J; Nie Y; Shi X; Lian G; Wang W; Yin X; Zhao Y; Qu X; Ding M; Deng H
    J Virol; 2004 Jul; 78(13):6938-45. PubMed ID: 15194770
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Identification of an HLA-A*0201-restricted CD8+ T-cell epitope SSp-1 of SARS-CoV spike protein.
    Wang B; Chen H; Jiang X; Zhang M; Wan T; Li N; Zhou X; Wu Y; Yang F; Yu Y; Wang X; Yang R; Cao X
    Blood; 2004 Jul; 104(1):200-6. PubMed ID: 15016646
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Structural characterization of the SARS-coronavirus spike S fusion protein core.
    Tripet B; Howard MW; Jobling M; Holmes RK; Holmes KV; Hodges RS
    J Biol Chem; 2004 May; 279(20):20836-49. PubMed ID: 14996844
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cleavage and serum reactivity of the severe acute respiratory syndrome coronavirus spike protein.
    Yao YX; Ren J; Heinen P; Zambon M; Jones IM
    J Infect Dis; 2004 Jul; 190(1):91-8. PubMed ID: 15195247
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Expression of recombinant spike protein of SARS-coronavirus in vaccinia virus and analysis of its immunogenicity].
    Hu S; Wang QH; Wang XJ; Wang XM; Bu ZG
    Bing Du Xue Bao; 2007 Jul; 23(4):287-91. PubMed ID: 17894231
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The SARS-CoV S glycoprotein: expression and functional characterization.
    Xiao X; Chakraborti S; Dimitrov AS; Gramatikoff K; Dimitrov DS
    Biochem Biophys Res Commun; 2003 Dec; 312(4):1159-64. PubMed ID: 14651994
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Potent neutralization antibody elicited in mice by SARS-associated coronavirus spike protein S1 domain].
    Zhang Y; Yang F; Li YH; Li WH; Tu XM; Wei Q; Zhu H; Liu L; Wang H; Qin C; Yuan GY; He W; Wang SH
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):258-60. PubMed ID: 15640862
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats.
    Liu RY; Wu LZ; Huang BJ; Huang JL; Zhang YL; Ke ML; Wang JM; Tan WP; Zhang RH; Chen HK; Zeng YX; Huang W
    Virus Res; 2005 Sep; 112(1-2):24-31. PubMed ID: 16022898
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prokaryotic expression, refolding, and purification of fragment 450-650 of the spike protein of SARS-coronavirus.
    Zhao JC; Zhao ZD; Wang W; Gao XM
    Protein Expr Purif; 2005 Feb; 39(2):169-74. PubMed ID: 15642467
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The spike protein of SARS-CoV--a target for vaccine and therapeutic development.
    Du L; He Y; Zhou Y; Liu S; Zheng BJ; Jiang S
    Nat Rev Microbiol; 2009 Mar; 7(3):226-36. PubMed ID: 19198616
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Production of a monoclonal antibody against SARS-CoV spike protein with single intrasplenic immunization of plasmid DNA.
    Yu XF; Liang LH; She M; Liao XL; Gu J; Li YH; Han ZC
    Immunol Lett; 2005 Sep; 100(2):177-81. PubMed ID: 15893826
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein.
    Bisht H; Roberts A; Vogel L; Subbarao K; Moss B
    Virology; 2005 Apr; 334(2):160-5. PubMed ID: 15780866
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus.
    See RH; Zakhartchouk AN; Petric M; Lawrence DJ; Mok CPY; Hogan RJ; Rowe T; Zitzow LA; Karunakaran KP; Hitt MM; Graham FL; Prevec L; Mahony JB; Sharon C; Auperin TC; Rini JM; Tingle AJ; Scheifele DW; Skowronski DM; Patrick DM; Voss TG; Babiuk LA; Gauldie J; Roper RL; Brunham RC; Finlay BB
    J Gen Virol; 2006 Mar; 87(Pt 3):641-650. PubMed ID: 16476986
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells.
    Du L; Zhao G; Li L; He Y; Zhou Y; Zheng BJ; Jiang S
    Biochem Biophys Res Commun; 2009 Jul; 384(4):486-90. PubMed ID: 19422787
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS.
    Callendret B; Lorin V; Charneau P; Marianneau P; Contamin H; Betton JM; van der Werf S; Escriou N
    Virology; 2007 Jul; 363(2):288-302. PubMed ID: 17331558
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus.
    Shih YP; Chen CY; Liu SJ; Chen KH; Lee YM; Chao YC; Chen YM
    J Virol; 2006 Nov; 80(21):10315-24. PubMed ID: 17041212
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Annexin A2 on lung epithelial cell surface is recognized by severe acute respiratory syndrome-associated coronavirus spike domain 2 antibodies.
    Fang YT; Lin CF; Liao PC; Kuo YM; Wang S; Yeh TM; Shieh CC; Su IJ; Lei HY; Lin YS
    Mol Immunol; 2010 Feb; 47(5):1000-9. PubMed ID: 20015551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.